Home » Newsletters » BioWorld Asia

BioWorld Asia

Dec. 1, 1999

View Archived Issues

Medigene Licenses Drug To Complement Work In HPV

Xenova Gets OK To Start U.S. Trial Of Cancer Drug

Other News To Note

Peptide's Study Of Product For Hay Fever Falls Short

Germans Discover Gene With Implications In Reproduction

European Commission Tries To Get Handle On GMO Issue

French Start-Up EntoMed Uses Insects In Platform Technology

Nexia Completes Financing To Further Develop BioSteel

Germans, Chinese Report On Methods To Research DNA

Biota Follows Up Flu Drug With Effort In Common Cold

Cambridge Antibody Brings Another Product Into Clinic

Celltech Plans Further Studies Of Anti-TNF Drug In Arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...